Publication:
Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice

dc.contributor.authorPimmada Jeamwattanalerten_US
dc.contributor.authorYuvadee Mahakunkijcharoenen_US
dc.contributor.authorLeera Kittigulen_US
dc.contributor.authorPakpimol Mahannopen_US
dc.contributor.authorSathit Pichyangkulen_US
dc.contributor.authorChakrit Hirunpetcharaten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherArmed Forces Research Institute of Medical Sciences, Thailanden_US
dc.date.accessioned2018-08-24T01:42:27Z
dc.date.available2018-08-24T01:42:27Z
dc.date.issued2007-04-01en_US
dc.description.abstractMerozoite surface protein 1 (MSP1) is the major protein on the surface of the plasmodial merozoite, and its carboxy terminus, the 19-kDa fragment (MSP119), is highly conserved and effective in induction of a protective immune response against malaria parasite infection in mice and monkeys. However, the duration of the immune response has not been elucidated. As such, we immunized BALB/c mice with a standard four-dose injection of recombinant Plasmodium yoelii MSP119 formulated with Montanide ISA51 and CpG oligodeoxynucleotide (ODN) and monitored the MSP119-specific antibody levels for up to 12 months. The antibody titers persisted constantly over the period of time without significant waning, in contrast to the antibody levels induced by immunization with Freund's adjuvant, where the antibody levels gradually declined to significantly lower levels 12 months after immunization. Investigation of immunoglobulin G (IgG) subclass longevity revealed that only the IgG1 antibody level (Th2 type-driven response) decreased significantly by 6 months, while the IgG2a antibody level (Th1 type-driven response) did not change over the 12 months after immunization, but the boosting effect was seen in the IgG1 antibody responses but not in the IgG2a antibody responses. After challenge infection, all immunized mice survived with negligibly patent parasitemia. These findings suggest that protective immune responses to MSP119 following immunization using oil-based Montanide ISA51 and CpG ODN as an adjuvant are very long-lasting and encourage clinical trials for malaria vaccine development. Copyright © 2007, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.citationClinical and Vaccine Immunology. Vol.14, No.4 (2007), 342-347en_US
dc.identifier.doi10.1128/CVI.00397-06en_US
dc.identifier.issn15566811en_US
dc.identifier.other2-s2.0-34248386524en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/24217
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34248386524&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleLong-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in miceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34248386524&origin=inwarden_US

Files

Collections